Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JLHY up big. I hope some folks here bought
gl promise me you won't sell till .01 :)
good post
I here that. I can't get away from 330k and oct 15th...gl
lots of folks talking about loving a chance for those twos. there they are.
today will test the strength of hands of all the "longs"
all you folks who want the 2's this may be your day. looks like you can buy and sell the 2's gl
OEGY will make your long term money happy
a premonition perhaps..gl
CEDA on the move again. Give it a look and it made this move on the day they announced a 1 for 3 reverse stock . That means the uplist is next and that the future is bright. Read the post this is responding to also for more insight or click the link for the yahoo home page
http://finance.yahoo.com/q?s=CEDA.OB
Press Release Source: China Education Alliance, Inc.
China Education Alliance, Inc. Announces One-for-three Reverse Stock Split
Thursday October 4, 2:00 am ET
HARBIN, China, Oct. 4 /Xinhua-PRNewswire-FirstCall /-- China Education Alliance, Inc. (OTC Bulletin Board: CEDA - News; the "Company"), a leading distributor of educational resources, offering high-quality programs and training both through online networks and an on-site training center in China, today announced a one-for-three reverse split of its common stock.
ADVERTISEMENT
On September 27, 2007, the Company's stockholders approved an amendment to the Company's certificate of incorporation that (i) changed the authorized capitalization to 20,000,000 shares of preferred stock and 150,000,000 shares of common stock and (ii) effected a one-for-three reverse split of the common stock. The Company anticipates that the reverse split will be effective for trading purposes on or about October 12, 2007. Prior to the amendment, the Company was not authorized to issue preferred stock.
"We believe the reverse stock split will place our company in a position to apply for listing on a market or exchange if we can meet the applicable listing requirements. Our goal is to work towards meeting listing standards," said Mr. Yu, Chairman and CEO of China Education Alliance, Inc.
As a result of the amendment to the certificate of incorporation, the board of directors has the power to set the rights, preferences, privileges and limitations with respect to one or more series of preferred stock, and the directors approved a series of preferred stock, designated the Series A Convertible Preferred Stock. As a result, notes in the principal amount of $3,400,000 that were issued in the May 2007 private placement were automatically converted into shares of series A preferred stock and warrants as previously disclosed.
About China Education Alliance, Inc.
The Company is an educational resource company offering high-quality educational programs and training through both online networks and an on-site training center. The Company's products include on-line test preparation materials, researchers' materials, study guides, and audio recordings, vocational training services and vocational certifications. The Company conducts educational services through three main channels: a large educational on-line portal, educational software and media, and education and vocational training centers. The Company is currently selling educational products and services to families, provincial education officials, administrators, schools and teachers in China.
Safe Harbor Statement
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release, constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, without limitation, statements regarding our ability to prepare the company for growth, the Company's planned expansion in 2007 and predictions and guidance relating to the Company's future financial performance. We have based these forward
You have strong hands IHUB. Stronger than mine. gl
SNTKY. IPRE I think it belongs in the ibox. I know there is an rs coming but it is an rs for all the right reasons. This stock is heading pre-rs for the 1.50 range. The volume is picking up. It is in play. No downside risk from here at all. They generate a lot of revenue andprofitability is right around the corner. Good for the Ibox..IMO
when you think about the long term potential of INIS you have to consider that the U.S. Gov.has committed to building 32 nuclear reactors over the next few years. Consider the uniqueness of the mkt niche that INIS services. Consider the new flourine purification proceses that they have developed that they are the only ones..without competition. consider the expertize and the opportunities for expanding the applications of what it is they do as the U.S. expands its nuclear capaccities. Opportunities foreseen and unforeseen. I would hold INIS for a very very long time as long as you didn't need the money in the present
there is no post on the bunm board that states what you said. that makes you a liar
did you get the name of the account rep. I will relate that anecdote tomorrow when i call and DEMAND my 2's just like you say did...gl
you did threaten to pull your account if they didn't. I call that a demand and what of it. And who else got 2's that you know , as you state..No one on this board has had any luck
pennysfromheaven says he got 2's by demanding it of his broker. What do you make of that. anyone? If it is that easy I will be calling ameritrade tomorrow and demanding a few million.
I think I'll raise my gtc to .034 as per Donleopoldos view of the future. from .01 a tidy profit of 135k of course you will have to chain me to a radiator to keep from selling sooner but it nice to look at glta longs
RMDX.....JLHY.....INIS..... ERFW is anyone out there with patient money
why do I like the look of the tape today? Maybe it is no longer business as usual. maybe there are a lot of people deep in "short" here. I like to see them pay a bundle on the cover. A little redistribution of wealth. glta longs
thanks, I sure would like the shorts to need my shares to cover. I would make them cry before they got 'em gl
well then I hope to see you posting all the way to a penny.gl
IHUB at some point the risk out weighs the reward. there are over 30,000 stocks out there. Once a stock has run a large percentage the risk is VERY LARGE because soo many people are holding profit. The new buyer sees the run up and says, I will wait for the dip or the retrace. The current holder says, I'm gonna take the money off the table and the bagholder says, this will go up forever. So I say consider strongly selling it and if it dips real low, you can buy it back. If it runs away from you who cares, there are 30,000 others to park your money on. IMO gl
what would happen if the ceo bought the whole float (legitimate float) and the only shares left in the publics hand were nss
SNTKY. trend line looks good. The r/s that is proposed of 8 to 1 will get them listed. very close to profitability. mkt cap about 26 million
Press Release Source: Senetek PLC
Senetek PLC Reports Second Quarter 2007 Financial Results
Monday August 13, 4:13 pm ET
Investor Conference Call Scheduled for August 17
NAPA, Calif., Aug. 13 /PRNewswire-FirstCall/-- Senetek PLC (OTC Bulletin Board: SNTKY - News), a specialty dermatology and skin care company targeting the science of aging, today announced financial results for the quarter ended June 30, 2007:
ADVERTISEMENT
Revenues for the second quarter 2007 were $471,000 compared to $2,005,000 for the same period in the prior year. The decline is attributed to the grant of a paid up license to Valeant Pharmaceuticals Inc. in the first quarter of 2007 which resulted in no Kinetin and Zeatin royalty revenues in the second quarter of 2007. Revenues for the six months ended June 30, 2007 were $25,779,000 compared to $4,274,000 for the same period in 2006. Revenues for the first half of 2007 included $24,750,000 recognized in conjunction with the previously announced grant of a paid up license for Kinetin and Zeatin to Valeant Pharmaceuticals Inc.
The Company realized a net loss of $397,000 (a loss of $0.01 per share) in the second quarter of 2007 compared to net income of $551,000 ($0.01 per share) in the second quarter of 2006. Net income for the six months ended June 30, 2007 totaled $21,336,000 ($0.35 per share) compared to net income of $538,000 ($0.01 per share) for the first six months of 2006. Net income for the six months ended June 30, 2007 included the effect of the previously announced grant of a paid up license for Kinetin and Zeatin to Valeant Pharmaceuticals Inc. and $1,320,000 from settlement of claims against a professional services provider for past performance related matters. The net income for the six months ended June 30, 2006 included a $927,000 non-cash expense for the write-off of the debt discount on retirement of the Senior Secured Notes and a $250,000 gain on the sale of Reliaject® assets.
In other developments during the quarter and through the date of this release:
-- The Company announced a Marketing Collaboration Agreement for its
second-generation cytokinin with Triax Aesthetics LLC, a Cranford, New
Jersey based company focused on quality of life for patients with
dermatologic conditions.
-- Under the terms of the Agreement, Senetek has granted Triax an
exclusive license in the ethical market channel in the United States
and its territories, Canada and select Middle East countries. All
product packaging will be labeled Senetek/Triax.
-- Senetek will be responsible for production and supply of products, will
contribute periodic sales and marketing payments totaling $4.5 million
in the first year of the Agreement and will participate in the product
marketing strategy. In return, Senetek will receive all net product
revenues in the first year of the Agreement, with a guaranteed minimum
of $10.8 million in 2008. The Agreement calls for increased minimum
sales annually after the first year. Subsequent to the first year of
the Agreement, the companies will share net revenues on a 50/50 basis.
Triax will be responsible for all sales, marketing and order
fulfillment during the life of the Agreement.
-- Significant advancement was made towards the successful bulk synthesis
of compound AK801 with finalization expected in September of this year.
-- The Company initiated safety testing of compound PA100 and expects
results in the fourth quarter of this year.
"Senetek financial results for the second quarter of 2007 were in line with the expectations set when we announced the Valeant paid up license transaction earlier this year," said Frank J. Massino, Senetek's Chairman and CEO. "We continue to be in the strongest financial condition that we have enjoyed in many years with $22 million of cash on hand at the end of the second quarter. Our recently announced marketing collaboration with Triax Aesthetics LLC and our advancements on new compounds are significant milestones in our strategy. Our marketing collaboration with Triax is the beginning of a new and superior business model which will increase revenues and create brand recognition for Senetek".
Senetek will conduct a teleconference call for investors on Friday, August 17, 2007 at 9:00 a.m. Pacific, 12:00 p.m. Eastern. The domestic dial-in number is 877-593-8638; the international dial-in number is 706-634-9240, conference ID 13177281. Mr. Frank J. Massino, Chairman & CEO and Mr. William F. O'Kelly, Chief Financial Officer, will discuss Company operations. Replay of the conference call will be available until August 24, 2007. Domestic Replay dial-in 800-642-1687, International Replay dial-in 706-645-9291, replay conference ID 13177281.
About Senetek PLC
Senetek PLC (OTC Bulletin Board: SNTKY - News) is a specialty dermatology and skincare company with a portfolio of intellectual properties targeting the science of aging, including skincare and dermatological therapeutics, erectile dysfunction and nutrition. Senetek recently granted Valeant Pharmaceuticals a paid up license for Senetek's first generation patented skin care active ingredient Kinetin and its analog Zeatin in return for $21 million cash and forgiveness of $6 million prepaid royalty credit, and is negotiating third party license agreements
gtec churned a lot of volume yesterday. I think it heads higher...Worth watching
good job IHUB don't be afraid to cash in
a watched pot never boils but surely the heat is on. we are in play. gl
yeah but hopefully someone else on this board has jumped in. That's the whole point. It won't stop here so plenty of upside left. We can't buy everything we dd but others might. GLTU and GLTA
EGMI keep an eye on it. This has too much rev in the pipeline to stay here ..Heading north. Ride it for 10 15 20 % or more gl
HABE see re-post from CBAY board. I can't do any real dd. I'm stuck using dial-up. Internet proper wll be down for 2 weeks they say but I am hoping not. IPRE what do you think of HABE...glta and keep posting some timely info.
OT: Kronus...
HABE (Haber, Inc.) is still currently a pinkie that is not a scam and is in fact on the road to incredible success... I have followed them and known the inventor (recently deceased) for over a decade...
Incredible, disruptive technology that is starting to garner attention around the world. Can extract Gold from ore concentrate NON TOXICALLY up to 20x faster than cyanide with higher yields.... solution is drinkable.... it IS currently in use and they just JV'd with a mining firm to work the 500 square miles of land they have in Ghana.... smack dab in the middle of some of the largest gold fields there...
Note too their Molecular invention. Can move and separate molecules faster than anyone on the planet... a new science only they have. Has been written up and is patented.. Company now being led by Ex Polariod and Raytheon Missile Defense men.... will be a good investment going forward.... I say 6x from current by next summer.... min..
a pinkie but real technology...needed. But most are scams...
This one runs, I'm dumping some back into HABE for the next leg up...
I like VRAL too... a 20x coming up there....
jmo... of course :) b
Public Reply | Private Reply | Keep | Last Read Replies (1) | Next 10 | Previous | Next
yes I do but I surely can't say that with any certainty. On the pinks nothing is what it appears to be and 90% of the time you will get hurt but once in a while thar is gold in those hills. I am hoping that this is one of those times. Will I have the strength to hold it that long should it run to a penny. I don't know. It is important to understand also that I am use to losing. I have gambled so much money away in my life that I am numb to loss. But the joy of hitting the lotto. Well I never get tired of that.
Be careful. Make sure you will not be crushed should you lose it all here because the odds are that this will disappoint many people. That's ok with me. I see something here that is worth a shot. A chance for big returns. Lots of risk ..good luck
stayed up for 12 months? micro pennies? Is anyone home?
RMDX has tons of volume holding up this pps. heading for $4 sooner or later. Pick an entry and ride it for .30 or more
jlhy is a slow creeping winner for someone. Hit another 52 week high.
here it is
Press Release Source: Genesis Technology Group, Inc.
Genesis Technology Group Merges With Chinese Pharmaceutical: 'Crowning Achievement' Says Management
Tuesday October 2, 9:34 am ET
BOCA RATON, Fla., Oct. 2, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) has entered into a reverse merger with a company that owns and controls Laiyang Jiangbo Pharmaceuticals Co., Ltd. (``LJPC''), a Chinese pharmaceutical company. For its fiscal year ended June 30, 2007, the Company reported total revenue of $76,000,000; net income of $22,000,000; total assets of $55,000,000; and cash on hand of $17,000,000.
ADVERTISEMENT
Located in a coastal city in Shandong Province, LJPC underwent an official audit by Moore Stephens Wurth Frazer and Torbet, LLP of Los Angeles, California, in addition to a rigorous due diligence process by Genesis management and consultants.
Based on research performed by a U.S. consulting firm and merchant bank, which inspected the LJPC facilities in Laiyang City last month, revenues have grown by an average of 187% over the previous two years, and net income has risen by an average of 748% over the same period.
Mr. Gary L. Wolfson, Genesis CEO since August 2002, reported: ``Since early 2003, Genesis management has earnestly and methodically sought a merger partner. Under the guidance of Dr. Shaohua Tan in China, we screened numerous candidates, and none could match the strength and potential of Laiyang Jiangbo Pharmaceuticals.
``It is an honor to turn over the future of the merged company to the leadership of Mr. Wubo Cao and his experienced team. Mr. Cao shall serve as the Chairman and Chief Executive Officer. It is our belief that the existing Genesis shareholders will be rewarded for their patience and dedication. In many ways, this merger is the crowning achievement of many years of effort and planning by Genesis management.
``The details of the merger will be explained fully in filings with the Securities & Exchange Commission and in a letter to be posted on our website http://www.Genesis-China.net,'' explained Mr. Wolfson.
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis ``Mission Statement.'' It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined ``partner companies.'' Genesis makes a long-term commitment with
GTEC wow nice day. Gonna take a closer look at that
You know I am not a chart reader. Do you still like the look of that chart. And do charts help much in triple zero land
Thanks I appreciate it. gltu
IPRE, I am not selling this. If it runs 1000%, I will be on it and if it goes to no bid, I will still be on it. What I see happening here is not common. This baby is churning high volume and I don't think it is so unreasonable for a stock to consolidate after a 500% run. I will be patient and I will be patient even after 500%. I want an FCCN run from .0049 to .055. AMEN